Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Dianthus Therapeutics (DNTH)
- 87.480
- +1.280+1.48%
Close Apr 8 16:00 ET
- 87.700
- +0.220+0.25%
Post 20:01 ET
4.42BMarket Cap-20.83P/E (TTM)
89.720High85.590Low1.03MVolume88.490Open86.200Prev Close90.42MTurnover2.18%Turnover RatioLossP/E (Static)50.54MShares89.72052wk High8.96P/B4.15BFloat Cap16.63552wk Low--Dividend TTM47.49MShs Float336.000Historical High--Div Yield TTM4.79%Range %5.136Historical Low87.502Avg Price1Lot Size
Dianthus Therapeutics (DNTH) Key Financial Indicators
DNTH Earnings per Share (EPS)
According to the latest financial report of Dianthus Therapeutics, the latest earnings per share (TTM) for the company is -1.43. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
DNTH Free Cash Flow (FCF)
Interested in knowing about Dianthus Therapeutics's free cash flow? The latest report shows it as -47.12M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
DNTH Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dianthus Therapeutics shows that the company's current ratio is 13.32, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
DNTH Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dianthus Therapeutics, the quick ratio is 13.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
DNTH Return on Equity (ROE)
Want to learn more about the financial health of Dianthus Therapeutics? The latest ROE figure is -12.39%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
DNTH Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dianthus Therapeutics, the total asset return on investment (ROA) is -11.63%.
Currency: USD
Quarterly
Loading...
DNTH Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dianthus Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
DNTH Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dianthus Therapeutics, the net profit margin is -22.69K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm